By Mauro Orru 
 

BASF SE said Monday that it has agreed with Sandoz GmbH, a subsidiary of Swiss pharmaceutical major Novartis AG, to make investments at the company's Kundl/Schaftenau Campus in Austria.

The German chemicals company didn't disclose financial details for the agreement signed on April 26, which is aimed at bolstering BASF's production footprint for enzymes and biotechnology products.

The start of production is planned for 2024, BASF said.

 

Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94

 

(END) Dow Jones Newswires

May 03, 2021 09:44 ET (13:44 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
BASF (XE:BAS)
Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more BASF Charts.
BASF (XE:BAS)
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more BASF Charts.